The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1
2014 1

Type 1 Diabetes Genetics Consortium 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication

CITE Title : Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication Personal Author(s) : Sharma, Shipra;Mayank, Adarsh K.;Nailwal, Himani;Tripathi, Shashank;Patel, Jenish R.;Bowzard, John B.;Gaur, Pratibha;Donis, Ruben O.;Katz, Jacqueline M.;Cox, Nancy J.;Lal, Renu B.;Farooqi, Humaira;Sambhara, Suryaprakash;Lal, Sunil K.; Published Date : 7 2014;7-2014; Source : FEBS J. 281(13):2899-2914 URL : https://stacks.cdc.gov/view/cdc/86988 Sharma, Shipra et al. (2014). Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication. 281(13). Sharma, Shipra et al. "Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication" 281, no. 13 (2014) Sharma, Shipra et al. "Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication" vol. 281, no. 13, 2014 Export RIS Citation Information.

:

Sharma, Shipra ;

Mayank, Adarsh K.

7 2014 | FEBS J. 281(13):2899-2914

:

Influenza A virus (IAV), similar to other viruses, exploits the machinery of human host cells for its survival and replication. We identified α‐act...
Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes

CITE Title : Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes Personal Author(s) : Robertson, Catherine C.;Inshaw, Jamie R. J.;Onengut-Gumuscu, Suna;Chen, Wei-Min;Santa Cruz, David Flores;Yang, Hanzhi;Cutler, Antony J.;Crouch, Daniel J. M.;Farber, Emily;Bridges, S. Louis;Edberg, Jeffrey C.;Kimberly, Robert P.;Buckner, Jane H.;Deloukas, Panos;Divers, Jasmin;Dabelea, Dana;Lawrence, Jean M.;Marcovina, Santica;Shah, Amy S.;Greenbaum, Carla J.;Atkinson, Mark A.;Gregersen, Peter K.;Oksenberg, Jorge R.;Pociot, Flemming;Rewers, Marian J.;Steck, Andrea K.;Dunger, David B.;Wicker, Linda S.;Concannon, Patrick;Todd, John A.;Rich, Stephen S.; Corporate Authors(s) : Type 1 Diabetes Genetics Consortium Published Date : 7 2021;7-2021; Source : Nat Genet. 53(7):962-971 URL : https://stacks.cdc.gov/view/cdc/108148 Robertson, Catherine C. et al. (2021). Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes. 53(7). Robertson, Catherine C. et al. "Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes" 53, no. 7 (2021) Robertson, Catherine C. et al. "Fine-mapping, trans-ancestral, and genomic analyses identify causal variants, cells, genes, and drug targets for type 1 diabetes" vol. 53, no. 7, 2021 Export RIS Citation Information.

:

Robertson, Catherine C. ;

Inshaw, Jamie R. J.

7 2021 | Nat Genet. 53(7):962-971

:

We report the largest and most diverse genetic study of type 1 diabetes (T1D) to date (61,427 participants), yielding 78 genome-wide-significant (P ...